ArticleInternational journal of molecular sciences2021

Known Drugs Identified by Structure-Based Virtual Screening Are Able to Bind Sigma-1 Receptor and Increase Growth of Huntington Disease Patient-Derived Cells.

Theo Battista et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.